INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
Right to try laws and requirements in North Dakota. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Have Enacted State Right to Try Laws | have state RTT laws | N.D. Cent. Code § 23-48-02“A manufacturer of an investigational drug, biological product, or device may make available the manufacturer's investigational drug, biological product, or device to an eligible patient pursuant to this chapter.” | Link | 2026-10-09 | high |
| Enacted Right to Try Laws Before Federal Law | 2015 | 2015 N.D. Sess. Laws, SB 2259 (codified at N.D. Cent. Code ch. 23-48)“AN ACT to create and enact chapter 23-48 of the North Dakota Century Code, relating to the use of experimental drugs; and to provide for a notification by the secretary of state.” | Link | 2026-10-09 | high |
| Require Individualized Manufacturer Approval for RTT | do not require individualized approval | N.D. Cent. Code § 23-48-01“"Investigational drug, biological product, or device" means a drug, biological product, or device that has successfully completed phase one of a clinical trial but has not yet been approved for general use”Note: Stored true is not supported. ND's only RTT law (ch. 23-48) is the classic terminal-illness/phase-one model; no individualized-treatment provisions. Searched full ND bill indexes for 2019, 2021, 2023 and 2025 sessions (ndlegis.gov) for 'individualized', 'investigational', 'experimental drug', '23-48', 'right to try': no individualized-treatment bill found (ND has no regular session in 2026). ND is also not in the reported list of enacting states. | Link | 2026-10-09 | high |
| Provide Manufacturer Liability Protection Under RTT | provide liability shield | N.D. Cent. Code § 23-48-05“This chapter does not create a private cause of action against a manufacturer of an investigational drug, biological product, or device or against any other person involved in the care of an eligible patient” | Link | 2026-10-09 | high |
| Require Insurer Coverage of Investigational Treatments | do not require coverage | N.D. Cent. Code §§ 23-48-01(4)(e), 23-48-04“States the patient's health insurer and provider are not obligated to pay for any care or treatments consequent to the use of the investigational drug, biological product, or device;” | Link | 2026-10-09 | high |
View full North Dakota profile (all layers) · Report an error on this page